ptpn14 open reading frame (Addgene inc)
Addgene inc is a verified supplier 
93
Structured Review
Addgene inc
ptpn14 open reading frame
Ptpn14 Open Reading Frame, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ptpn14+open+reading+frame/pCDNA3-V5-PTPN14-wild+type+(Plasmid+%2361003)/pm30559405-192-21-30
Average 93 stars, based on 5 article reviews
Ptpn14 Open Reading Frame, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ptpn14+open+reading+frame/pCDNA3-V5-PTPN14-wild+type+(Plasmid+%2361003)/pm30559405-192-21-30
Average 93 stars, based on 5 article reviews
ptpn14 open reading frame - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma Article Snippet: For studying in vivo effects, stable miR-4516-overexpressing U87MG/ EGFR vIII-luc and GBM30-luc cells were generated by lentiviral transduction (Sigma). Transfection:Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Article Snippet: Transfection of miR-4516 mimics and inhibitors, siRNA treatment, plasmids, and lentiviral transduction For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/ L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma Article Snippet: For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing Negative Control:Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Article Snippet: Transfection of miR-4516 mimics and inhibitors, siRNA treatment, plasmids, and lentiviral transduction For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/ L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma Article Snippet: For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing Plasmid Preparation:Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Article Snippet: Transfection of miR-4516 mimics and inhibitors, siRNA treatment, plasmids, and lentiviral transduction For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/ L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing Article Title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma Article Snippet: For functional studies, a specific miR-4516 mimic/inhibitor (Ambion) and a respective negative control (Ambion) were transfected into the GBM cells. .. For siRNA transfection, a specific PTPN14 siRNA (50 nmol/L) (OriGene) and a negative control were used. pcDNA3/ PTPN14 plasmid containing |